U.S. Residential REITs Stock News

NasdaqGM:SNFC.A
NasdaqGM:SNFC.ADiversified Financial

Security National Financial (SNFC.A) Stock Looks Cheap As Margins Firm and Sales Slip

Security National Financial barely moved in regular trading on Tuesday, slipping just 0.1% to about $9.31, even though the latest quarter quietly reset the earnings story. The headline is profit quality. Basic earnings per share came in at roughly $0.34 in Q2, above Q1, and trailing earnings now support a P/E of about 6.9x while the broader peer group trades at roughly double that multiple. In the short term, the stock appears relatively inactive. Over a multi-year view, the combination of a...
NYSE:SNOW
NYSE:SNOWIT

Snowflake (SNOW) Could Be 24% Undervalued On AI Deals And $6b AWS Commitment

Snowflake (SNOW) is back in focus after a series of AI related moves, including new partner integrations, the launch of Cortex AI Gateway, and a multiyear US$6b commitment with Amazon Web Services. See our latest analysis for Snowflake. The recent AI focused announcements appear to line up with a strong acceleration in Snowflake’s share price, with a 30 day share price return of 27.8% and a 90 day gain of 119.3%, while the 1 year total shareholder return of 73.1% points to powerful momentum...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

The Bull Case For Lincoln Electric Holdings (LECO) Could Change Following Strong Q2 Earnings And Major Buybacks

In the second quarter of 2026, Lincoln Electric Holdings reported higher sales of US$1,219.66 million and net income of US$158.52 million, with both basic and diluted earnings per share from continuing operations increasing compared to a year earlier. Over the same period, the company continued to shrink its share count, completing a multi‑year buyback that retired 9.48% of its shares for US$1.04 billions, which amplifies the impact of its earnings growth on each remaining share. With this...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Tango Therapeutics (TNGX) Stock Faces Cash Burn Pressure After Revenue Vanishes

Tango Therapeutics dropped about 5% today to US$26.34, yet the real story sits on the income statement. The company is still a development stage oncology player and the headline this half is the squeeze in profitability. Management reported a basic loss per share of US$0.69 for the first half of 2026 and a net loss of roughly US$100.9m, while revenue rounded to zero. For a stock that has swung sharply over the past month, the key question now is how long the balance sheet can keep funding...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum (AMTM) Stock Drops Despite Margin Strength And Higher EPS Outlook

Amentum Holdings woke up to a sentiment shock. The stock dropped about 8% to around $22.40, even though the headline from this earnings release was margin power, not revenue strain. Adjusted earnings per share reached $0.67 and adjusted EBITDA margin stood at 8.3%. Both landed ahead of what many investors had been braced for in a government services contractor with modest revenue growth. The market is reacting as if a growth story has cracked. The numbers point instead to a quarter where...
NYSE:LCLN
NYSE:LCLNCapital Markets

Lincoln International (LCLN) Stock Faces Margin Questions After Record Revenue

Lincoln International came into this earnings print with its stock quietly grinding higher, up over the past month and little changed on the day at about US$24.36. The market reaction looks muted compared with the headline from the quarter. Revenue hit roughly US$226 million and management reported an adjusted operating margin of 20%, putting the profit squeeze and its direction at the center of the story. For an advisory-focused investment bank, the key issue for you now is simple: Do these...
NYSE:EVC
NYSE:EVCMedia

Entravision Communications (EVC) Stock Sinks As Ad Tech Durability Faces Scrutiny

Entravision Communications just watched its stock drop 21% in a day, yet the headline story is not a collapse in its media business. The shock came as the market weighed a sharp price reset against quarterly numbers that showed advertising technology revenue helping drive consolidated sales to about US$227.9m and lifting operating income into positive territory. Coming into this report, the stock had already slipped about 21% over the past month. Today's reaction suggests investors are...
NYSE:ELF
NYSE:ELFPersonal Products

Why e.l.f. Beauty (ELF) Is Up 8.1% After Raising 2027 Sales Guidance And Earnings Outlook

In early August 2026, e.l.f. Beauty reported strong fiscal first-quarter results, with net sales rising to US$479.37 million and net income reaching US$66.6 million, and management raised fiscal 2027 net sales guidance to US$1.94 billion–US$1.97 billion alongside higher earnings expectations. The company also extended its streak of 30 consecutive quarters of net sales growth while launching an innovative, rapidly selling hybrid collection with Bubble and gaining marketing recognition through...
NYSE:JBGS
NYSE:JBGSOffice REITs

JBG SMITH Properties (JBGS) Stock Rebound Hinges On FFO As Losses Deepen

JBG SMITH Properties stock ticked up 1.6% to US$11.39 into the close, even though the latest quarter again underscored how hard it is for office landlords to convert rents into clean profits. The headline this time is not the loss on the income statement. It is the rebound in funds from operations, the real estate investment trust cash flow yardstick, to US$12.5 million in the quarter. For a stock that is down sharply over the past three months, that FFO improvement is what bulls will focus...
NasdaqGS:GILT
NasdaqGS:GILTCommunications

Gilat Satellite Networks (GILT) Stock Faces Cash Flow Questions After Revenue Growth

The market gave Gilat Satellite Networks only a modest nod today, with the stock up about 1.6% after a rough three months that saw the share price fall almost 29%. That muted bounce sits against a quarter that was all about operating strength rather than headline drama. Revenue reached about US$122.7m and adjusted EBITDA margin moved into the low teens, which matters in a capital intensive satellite communications business where cash generation and profitability often drive the real...
NYSE:ALB
NYSE:ALBChemicals

Albemarle (ALB) Earnings Beat Raises A Bigger Question About Value

Why Albemarle’s latest earnings matter for investors Albemarle (ALB) reported second quarter 2026 earnings on August 5, with higher sales and net income than a year earlier, alongside full year guidance and an update on lithium volumes. See our latest analysis for Albemarle. Since the earnings release on 5 August, Albemarle’s recent 7 day share price return of 7.07% contrasts with a 90 day share price decline of 35.62% and a 1 year total shareholder return of 68.13%, which signals recovering...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva (TEVA) Is Up 6.0% After Moody’s Upgrade To Investment Grade And Higher 2026 Guidance

In late July 2026, Teva Pharmaceutical Industries reported second-quarter results showing broadly flat sales of US$4,142 million but a shift from net income of US$282 million a year earlier to a net loss of US$576 million, alongside lower impairment charges and confirmation it had completed a long-running US$2,567.52 million share repurchase program launched in 2011. On the same day, Teva raised its 2026 revenue guidance, outlined mid-single-digit revenue growth targets for 2027, and...
NYSE:SGHC
NYSE:SGHCHospitality

Why Super Group (SGHC) Is Down 6.8% After Raising 2026 Revenue Guidance Above US$2.60 Billion

Super Group (SGHC) Limited recently reported second-quarter 2026 results, with sales rising to US$684 million and net income improving to US$120 million, and it raised full-year 2026 total revenue guidance to more than US$2.60 billion from over US$2.55 billion. The shift from a small net loss a year ago to solid profitability in the latest quarter highlights how operational and earnings momentum have strengthened across the business. Next, we’ll examine how the upgraded full-year revenue...
NYSE:MPLX
NYSE:MPLXOil and Gas

MPLX (MPLX) Stock Looks Fairly Valued With Cheap Earnings But Funding Risk

MPLX has rewarded long term holders with a 228.0% total return over the past five years, which now puts more focus on whether the current price still offers value or is already reflecting much of that progress. Recent valuation checks screen MPLX as undervalued on traditional multiples, but the broader scorecard suggests the picture is more balanced. The 228.0% five year return signals that MPLX has already delivered strong gains for investors, so fresh buyers need to think carefully about...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Oklo (OKLO) Reaches First Criticality, Is The Stock Still Undervalued?

Oklo (OKLO) has just crossed two important thresholds. The company achieved first criticality at its Groves Isotope Test Reactor and reported its first quarterly revenue, giving investors fresh information on both execution and early commercialization. See our latest analysis for Oklo. Oklo’s recent first criticality and initial revenue have come against a mixed trading backdrop, with the share price up 5.66% over the last day and 8.49% over the week, yet down 39.58% year to date, while the...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

Middleby (MIDD) Stock Slides As Margin Pressure Hits Pure Play Pivot

Middleby stock just took an almost 8% hit to around US$120, even though the headline from Q2 is a cleaner, more focused business with solid Commercial Foodservice momentum. The quarter landed with about US$876m of revenue and adjusted earnings power centered in Commercial Foodservice, which posted strong organic growth and a mid 20s adjusted EBITDA margin. The real story for you is not a single quarter of EPS; it is a newly pure play foodservice equipment company facing a margin squeeze in...
NYSE:SNDA
NYSE:SNDAHealthcare

Sonida Senior Living (SNDA) Stock Price Slides As Valuation Gap Widens

Sonida Senior Living just handed short term traders a 7.3% price hit, with the stock closing near US$38.90 after the Q2 earnings release. The headline is not the red ink on the income statement. It is how much operating cash generation is starting to matter more than accounting losses. Quarterly revenue reached about US$196.7m and normalized funds from operations per share came in at US$0.48. Those are the numbers long term investors will keep circling, especially against a stock that still...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Can Nebius Group’s (NBIS) New CMO Strengthen Its AI Infrastructure Investment Narrative?

Nebius Group recently appointed former Square executive Lindsey Irvine as Chief Marketing Officer to support its global expansion, while investors focus on the company’s pending Q2 2026 earnings release and AI cloud infrastructure growth story. This combination of leadership change and heightened interest in Nebius’ role in building physical AI infrastructure is sharpening attention on how sustainably it can convert demand into long-term business strength. Against this backdrop, we’ll...
NYSE:JBI
NYSE:JBIBuilding

Janus International Group (JBI) Stock Sinks On Margin Compression And EBITDA Cut

Janus International Group stock closed at US$5.06, down almost 6% on the day, as investors reacted to a headline that was less about revenue softness and more about profitability pressure. Q2 adjusted EBITDA margin compressed to roughly 17% even though revenue reached US$233.5m, and management cut full year EBITDA guidance to US$150m to US$170m. Short term traders are focusing on that margin squeeze and the guidance reset. Longer term investors are now weighing those pressures against the...
NYSE:HUYA
NYSE:HUYAEntertainment

HUYA (HUYA) Stock Eyes Turnaround As Game Services Rebuild Profit

HUYA went into this earnings print priced like a problem stock. The shares sit near ¥2.42 after a flat 1 day reaction and a drop of about 21% over the past three months. The headline this quarter is simple: the gaming and live streaming platform finally put real numbers behind its turnaround story. Revenue reached ¥1.74b for Q2, with game related services and advertising now a much larger slice of the business. HUYA also inched back into positive earnings per share at ¥0.01 and narrowed...
NasdaqGS:TNXP
NasdaqGS:TNXPBiotechs

Tonix Pharmaceuticals (TNXP) Revenue Surge Meets Persistent Cash Burn Concerns

Tonix Pharmaceuticals Holding came into this earnings print with a choppy recent run, roughly flat over the past week and down about 11% over three months. The stock slipped about 2% today, yet the headline from the quarter is not the share price. The key story is the revenue ramp from its fibromyalgia franchise, with Q2 revenue of about US$13.5 million driven largely by TONMYA sales and paired with a sizeable net loss of roughly US$40.6 million. Interested in Tonix Pharmaceuticals Holding's...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Why Hut 8 (HUT) Is Down 12.2% After Massive Q2 Loss and $7.5 Billion Expansion Plan

In the past quarter, Hut 8 Corp. reported second-quarter 2026 revenue of US$74.93 million, up from US$41.30 million a year earlier, while swinging from net income of US$137.31 million to a net loss of US$150.19 million. Alongside tripled bitcoin production and very large long-duration project financing of US$7.50 billion for its River Bend and Beacon Point campuses, Hut 8 is pairing rapid infrastructure expansion with a commitment to responsible data center development and community...
NasdaqGM:TLS
NasdaqGM:TLSSoftware

Telos (TLS) Stock Jumps As Margin Recovery Starts To Look Real

Telos stock jumped 6.5% to US$4.29 today, a sharp move for a company that has spent the past month drifting about 12% lower. The spark is not a revenue surprise; it is the earnings quality. Telos turned in US$47.7m of Q2 revenue with a 14.4% adjusted EBITDA margin, plus a 13.9% free cash flow margin that allowed the company to keep buying back stock. For a cyber and government IT contractor that only recently pulled out of heavy losses, this kind of margin profile is what investors have been...
NasdaqGM:GCMG
NasdaqGM:GCMGCapital Markets

GCM Grosvenor (GCMG) Stock Sees Fee Strength Clouded By SpaceX Risk

The market is only giving GCM Grosvenor a gentle nod, with the stock up about 1% to US$13.98 after the Q2 print. That is a muted move for an alternative asset manager that just reported fee related earnings of roughly US$50 million on US$134 million of revenue and a solid quarterly rise in assets under management. Price action suggests investors are still trying to separate durable fee power from the headline excitement around SpaceX linked gains. Is GCM Grosvenor’s sub industry P/E and...